{"id":7112,"date":"2026-03-01T23:59:14","date_gmt":"2026-03-01T23:59:14","guid":{"rendered":"https:\/\/live-cancer-factfinder.pantheonsite.io\/fact-finder-tool\/bwe-bwason-ki-two-cho-ka-ogmante-risk-ou-genyen-pou-kanse-cancer-fact-finder\/"},"modified":"2026-10-01T22:51:33","modified_gmt":"2026-10-01T22:51:33","slug":"bwe-bwason-ki-two-cho-ka-ogmante-risk-ou-genyen-pou-kanse-cancer-fact-finder","status":"publish","type":"post","link":"https:\/\/cancerfactfinder.org\/ht\/zouti-pou-cheche-enfomasyon\/bwe-bwason-ki-two-cho-ka-ogmante-risk-ou-genyen-pou-kanse-cancer-fact-finder\/","title":{"rendered":"AFIKASYON: Bw\u00e8 bwason ki tw\u00f2 cho ka ogmante risk pou ou gen kans\u00e8"},"content":{"rendered":"\n

Sa ou ka tande<\/h2>\n\n

Konsomasyon bwason ki tw\u00f2 cho souvan, tankou te ak mate, ka ogmante risk pou ou devlope kans\u00e8 nan \u00e8zofaj.<\/p>\n\n

Sa syans lan di nou<\/h2>\n\n

Bw\u00e8 bwason cho plizy\u00e8 fwa ka domaje pawa \u00e8zofaj la, sa ki ka ogmante risk kans\u00e8 sou tan. Ajans Ent\u00e8nasyonal pou Rech\u00e8ch sou Kans\u00e8 (IARC) klase bwason ki pi cho pase 65\u00b0C oswa 149\u00b0F k\u00f2m bwason ki posibman kanseroj\u00e8n pou moun<\/em><\/strong> (Gwoup 2A). Sa vle di se tanperati ki wo, pa bwason an li menm, ki ka gen enpak sou risk kans\u00e8 a. Kalite kans\u00e8 \u00e8zofaj<\/a> ki pi souvan asosye av\u00e8k bwason ki tr\u00e8 cho se karsinom selil skameuz<\/strong> . <\/p>\n\n

Pr\u00e8v Epidemyolojik<\/h3>\n\n

Pif\u00f2 etid obs\u00e8vasyon\u00e8l yo te f\u00e8t nan popilasyon ki souvan bw\u00e8 bwason ki tr\u00e8 cho epi yo sijere ke risk kans\u00e8 a ogmante ak tanperati a. <\/p>\n\n

    \n
  • Yon meta-analiz<\/strong> sou etid obs\u00e8vasyon\u00e8l yo te jwenn yon risk siyifikativman ogmante pou kans\u00e8 selil skameuz nan mitan moun ki te bw\u00e8 te cho (Luo et al.).<\/li>\n\n\n\n
  • Yon etid ka-temwen<\/strong> nan Kenya rap\u00f2te ke moun ki bw\u00e8 bwason “tr\u00e8 cho” ak “cho” te gen 3.7 ak 1.4 fwa plis chans, respektivman, pou yo devlope kans\u00e8 nan \u00e8zofaj konpare ak moun ki bw\u00e8 bwason ty\u00e8d (Middleton et al.). <\/li>\n\n\n\n
  • Yon etid kow\u00f2t<\/strong> an 2025 nan Way\u00f2m Ini a te obs\u00e8ve tou yon ogmantasyon risk pou kans\u00e8 selil skam\u00e8z pami moun ki te bw\u00e8 te ak kafe tr\u00e8 cho (Inoue-Choi et al.). Risk la te ogmante ak kantite tas yo te konsome pa jou. <\/li>\n<\/ul>\n\n

    Pr\u00e8v Laboratwa\/Pr\u00e8v Sip\u00f2<\/h3>\n\n

    Yon etid laboratwa te jwenn ke bw\u00e8 dlo tr\u00e8 cho (70\u00b0C) te ankouraje devlopman kwasans an\u00f2mal bon\u00e8 yo rele lezyon premalign<\/strong> nan \u00e8zofaj rat yo, sa ki ta ka ogmante risk kans\u00e8 (Rapozo et al.).<\/p>\n\n

    Kijan pou diminye risk ou<\/h2>\n\n

    Kite bwason cho yo refwadi pou k\u00e8k minit anvan ou bw\u00e8 yo epi evite bw\u00e8 nenp\u00f2t bagay ki cho tw\u00f2p. Si li boule bouch ou, li ka irite pawa \u00e8zofaj ou. <\/p>\n\n

    Liy final la<\/h2>\n\n

    Bw\u00e8 bwason ki pi cho pase 65\u00b0C (149\u00b0F) regily\u00e8man ka ogmante risk pou kans\u00e8 nan \u00e8zofaj, patikily\u00e8man karsinom selil skam\u00e8z. Enkyetid yo lye ak tanperati a, pa kalite bwason an. Pandan ke tanperati s\u00e8vi yo varye atrav\u00e8 lemond, li pi an sekirite pou kite bwason cho yo refwadi anvan ou bw\u00e8 yo pou diminye risk ou. <\/p>\n","protected":false},"excerpt":{"rendered":"

    Sa ou ka tande Konsomasyon bwason ki tw\u00f2 cho souvan, tankou te ak mate, ka ogmante risk pou ou devlope kans\u00e8 nan \u00e8zofaj. Sa syans lan di nou Bw\u00e8 bwason cho plizy\u00e8 fwa ka domaje pawa \u00e8zofaj la, sa ki ka ogmante risk kans\u00e8 sou tan. Ajans Ent\u00e8nasyonal pou Rech\u00e8ch sou Kans\u00e8 (IARC) klase bwason…<\/p>\n","protected":false},"author":9,"featured_media":7114,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[545],"tags":[472],"class_list":["post-7112","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-rejim-alimante-ak-nitrisyon","tag-definitivman-oswa-pwobableman-vre"],"acf":[],"_links":{"self":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/7112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/comments?post=7112"}],"version-history":[{"count":4,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/7112\/revisions"}],"predecessor-version":[{"id":14021,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/7112\/revisions\/14021"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media\/7114"}],"wp:attachment":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media?parent=7112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/categories?post=7112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/tags?post=7112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}